|Bid||49.60 x 800|
|Ask||49.64 x 4000|
|Day's Range||49.53 - 49.89|
|52 Week Range||42.10 - 50.84|
|Beta (3Y Monthly)||0.30|
|PE Ratio (TTM)||31.54|
|Earnings Date||Jul 23, 2019 - Jul 29, 2019|
|Forward Dividend & Yield||1.60 (3.26%)|
|1y Target Est||51.95|
Uber (UBER) is releasing its first Q1 earnings after market close on Thursday, May 30th. Both Uber and Lyft went public at a massive bottom-line deficit, with no profits in sight.
[Editor's Note: This article was updated to correct the price-to-sales ratio.]Usually I don't like to invest in small-cap companies but New Age Beverages Corporation (NASDAQ:NBEV) is interesting to trade as a speculative bet for the next few months or maybe years.NBEV is a beverage provider, so I consider it as part of the consumer staples group, which includes great companies like Proctor and Gamble (NYSE:PG), Coke (NYSE:KO) and Pepsi (NASDAQ:PEP).InvestorPlace - Stock Market News, Stock Advice & Trading TipsAlthough it's in the same group as Coke and Pepsi, I do consider NBEV an alternative beverage provider. It's perfectly set up to pursue the cannabis opportunities, specifically the potables.The popularity of cannabis based or infused products has skyrocketed of late and the possibilities are endless. Evidence of this is the popularity of pot stocks like Canopy Growth (NYSE:CGC), Cronos (NASDAQ:CRON) and Tilray (NASDAQ:TLRY). These are intrepid companies trying to establish a new world of opportunities. So this can be a blank canvas for companies like NBEV and and I bet that they will partake in it. Looking at Marijuana Stocks and NBEV StockThe cannabis craze isn't just marijuana stocks -- it now includes CBD products and services. From what I hear, people call it the cure for just about every ailment on the planet. Although there is sarcasm here, I am reporting what I hear even from my friends and family. Everyone who uses it swears it did the trick and that's all that matters.Last year NBEV announced that they will serve potables infused with CBD. So they too will be on the band wagon. This is a trend that is not short term fad. The passion for cannabis from its fans is rare even stronger than Bitcoin. So the movement has legs and evidence is that the major mega cap companies are all rumored to be looking into this too. * 5 Safe Stocks to Buy This Summer On its own, New Age Beverages stock is not cheap. This is a company that loses money and sells at 5x sales. So clearly Wall Street gives it a lot of leeway for now. They just reported earnings and even though they missed expectations they grew sales 400%. But this stock draws enough shorting interest that I bet it could sport a short squeeze sometime this year.NBEV stock is now far from its high but still is popular among investors. It is still up 212% in a year while the S&P 500 is barely green. A fairer comparison is to the Consumer Staples Select Sector SPDR Fund (NYSEARCA:XLP) which is only up 15% for the same period.There is a good chance that NBEV stock entices shorts to bet against extreme moves up or down. So it's a matter of time before it catches fire.Today's thesis is that the overall market weakness we are getting here is an opportunity to bet long on NBEV stock to capture such spike. Once this wave of negative sentiment reverses investors will buy almost every stock up with vigor. But for the controversial stocks like this one they tend to buy them faster.Regardless of the magnitude, the bulls could cause it to breakout above $5.65 per share and that would be a trigger to target $6.70 where it last failed in April. There will be resistance around $6.1 along the way. Above the April fail would bring the sky as the limit.What also makes this possible is that for the last few months, New Age Beverage stock has established a zone of support just below current price. So the bulls have a strong platform from which to mount their efforts.This is not the same as saying that I like the fundamentals; I am agnostic on that front. I consider this a highly speculative and almost binary bet for profit. Since there is less science than hopium, it is important to properly size the gamble. And this is a gamble -- don't bet the farm, choose an amount that won't break your heart or your piggy bank.In addition to the intrinsic risks from the stock itself, I have to contend with the general market malaise from the tariff wars. It seems that the headlines are going to linger for at least another month.Scared markets don't usually buy frothy stocks like New Age. But when investors come to terms with the China risks, then they will buy the riskiest stocks the fastest. In other words, momentum stocks move faster in both directions, so I expect fireworks in NBEV stock soon after the markets stabilize from this tizzy.Nicolas Chahine is the managing director of SellSpreads.com. As of this writing, he did not hold a position in any of the aforementioned securities. You can follow him as @racernic on Twitter and Stocktwits. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 5 Safe Stocks to Buy This Summer * The 5 Best Telecom Stocks to Buy Now * 6 Innovative Stocks With Big Long-Term Growth Potential Compare Brokers The post New Age Beverages Stock Could Surge to $6.70 appeared first on InvestorPlace.
Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date. What Happened? On this day 34 years ago, Quantum Computer Sciences was founded in Delaware. Where The ...
The soda and beverages industry is set to gain from the removal of aluminum tariffs since it predominantly uses imported aluminum for packaging its products.
Stock investors seeking to profit from fast-growing demand for CBD -- the non-intoxicating ingredient derived from marijuana used in everything from medicines to foods -- should look closely at six stocks, according to a team at Piper Jaffray. Stocks best positioned to gain include pure-play companies that sell CBD concentrates, such as Charlotte’s Web Holdings (CWEB.Canada), CV Sciences Inc. (CVSI), Elixinol Global Ltd. (EXL.Australia), and Isodiol International Inc. (ISOL.Canada). Another top CBD-related pick includes GW Pharmaceuticals PLC (GWPH), which currently has the only FDA-approved drug derived from CBD for treating childhood epilepsies.
In early April I wrote about going long Canopy Growth (NYSE:CGC) stock. That trade paid off quickly but after peaking at $52.50 per share CGC stock gave it back and has reverted to support. While this sounds disappointing it is where the opportunity lies today.Source: Shutterstock It is time to reload almost exactly the same CGC trade as before. I consider this a blend of tactical trade with the potential to making it a long-term investment. It all depends on the investor time frame. The difference will be how to manage the trade if price goes against it. But in either case the start is the same. But First, Canopy Growth FundamentalsThe whole cannabis stock sector is speculative at best. Companies like Canopy Growth are trying to establish a legitimate business on Wall Street for the first time ever. This is not an easy feat and they are facing hurdles.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe regulatory obstacles are also opportunities which eventually will be incremental upside. There is no doubt that the bullish thesis for pot stocks is strong. * 5 Great Tech ETFs That Aren't the XLK Bottom line, the popularity of pot is what drives the fanatical interest in these stocks.This is not a fad. The interest is too strong to fizzle. Also there is too much action from mega-cap companies who are seeking to join the party if not already there. CGC was ground zero for this when it took $4.5 billion from Constellation Brands (NYSE:STZ). More investments followed like the one into Cronos (NASDAQ:CRON) from Altria (NYSE:MO).Also the cannabis story is not local. This is a global phenomena but the markets here in North America are probably the sexiest to investors. Simply stated, the story is too good to dismiss so soon.CGC stock is not for the faint of heart. They are called momentum stocks because they move fast in both directions. Case in point, yesterday it rose 4% on no specific news. So this makes it difficult to find the perfect trading points. So it is best to learn the levels that matter and use those as entry and exit lines. Trading CGC StockOnce CGC fell back into the $43 zone it slowed its deceleration because that is a support zone. These are not hard lines in the sand but rather rubber bands. I can buy it here and expect a bounce towards the last place it failed.If will face resistance at $49 per share so I should lock profits once it reaches it. But this varies based on individual trading preferences and time frames. If it's a tactical trade then I'd set my stop loss below $41.75 or $39.75 per share. Because if those fail, the bears could try to retest $33 per share. This is not a forecast but a scenario that could unfold.The CGC stock fundamentals are the best of the bunch on paper. This is not to say that they are good. But they did receive the pile of cash from STZ and they are putting it to good use. Their strong balance sheets allows them to execute on plan comfortably. But they still need to grow their delivery capacity.This is what Wall Street believes, and whether reality or not, perception is all that counts this early in the process.Critics of cannabis do make valid arguments. But for every point of contention they offer, there are several other facets of the cannabis that offset that one negative. The applications for cannabis includes not just recreational use, but also medical, CBD, potables, edibles, etc.So according to Wall Street we will smoke it, eat it, drink and rub it on our ailments. So to be a bear on cannabis now is like fighting a multi-headed beast. They can shoot down one aspect of the bullish thesis but there are several more that can still bite the sellers.Nevertheless, it is important to temper the enthusiasm. Canopy Growth fundamentals from the traditional point of view are scary. And it is not alone as the whole sector carries very rich valuation with minimal opposing income. CGC has a market cap of $15 billion and only has a small fraction of it in sales.So yes, they are expensive but the story is not in today's dollar but rather several years out. The legalization trend is just starting. As more states follow the early movers, the North America consumption markets will grow exponentially.Canopy is set to be able to cater to the incremental demand. They are literally forging the trail for the others to follow. Recently we saw them execute an inventive way of acquiring resources without breaking any laws. This is a team that is not afraid to make bold moves and take calculated risks. * 7 Safe Stocks to Buy for Anxious Investors If cannabis stocks are a viable thesis long term, then Canopy Growth is a winner. So far, CGC and ACB are up more than 65% year to date -- four times the performance of the S&P 500.Nicolas Chahine is the managing director of SellSpreads.com. As of this writing, he did not hold a position in any of the aforementioned securities. You can follow him as @racernic on Twitter and Stocktwits. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Safe Stocks to Buy for Anxious Investors * 4 Tech Stocks Looking Vulnerable * Should You Buy, Sell, Or Hold These 7 Hot IPO Stocks? Compare Brokers The post It's Time to Load Up on CGC Stock Again appeared first on InvestorPlace.
Coca-Cola Brings Back New Coke for Stranger ThingsNew Coke is backCoca-Cola (KO) will offer a limited edition of its of New Coke cans beginning May 23 as part of its partnership with Netflix’s (NFLX) show Stranger Things. Season 3 of Stranger
Coca-Cola is reviving its infamous New Coke, which will take a prominent role in Season 3 of Netflix hit "Stranger Things."
Coca-Cola is partnering with Netflix to bring back New Coke to promote the third season of "Stranger Things."
NEW YORK (AP) — Coca-Cola drinkers will get a chance to relive one of the company's darker chapters as New Coke makes a comeback under a partnership with the Netflix drama "Stranger Things," the companies announced Tuesday.
The vote follows recent statements by district attorneys from metro Atlanta counties, including Fulton and DeKalb, that they would not prosecute pursuant to the state legislation known as HB 481.
Back in January, The National Restaurant Association released its annual list of top trends in the restaurant and food industry. Drink companies are looking to get in on the cannabis craze, with companies looking at possibilities for adding the substance to everything from beer to spirits to water. Research from ArcView says the cannabis edibles market will hit $4.1 billion by 2022, and some of that surely will be in restaurants, because who wants to cook?
Welcome to the latest episode of the Full-Court Finance podcast from Zacks Investment Research where Associate Stock Strategist Ben Rains breaks down Beyond Meat, Inc. (BYND) and its recent IPO that has seen it destroy Uber (UBER) and Lyft (LYFT).
Warren Buffett is a fan of dividends. Just look at all the dividend stocks that fill Berkshire Hathaway's (NYSE:BRK.B),NYSE:BRK.A) portfolio. Many of his top holdings send plenty of cash flowing back into BRK.B's coffers, inflating them by billions of dollars each quarter. And for decades, BRK.B has been using those dollars to reinvest and drive the future returns of Berkshire Hathaway stock.Source: Shutterstock However, despite Buffett's love of stocks that pay dividends, Berkshire Hathaway stock doesn't pay one of its own, with Buffett preferring to use the money for other purposes. Over the years, that's been a fine approach. But these days, Buffett and BRK.B may want to rethink that stance. * 7 High-Yield REITs to Buy (Even When the Market Tanks) A huge cash pile, underperformance in recent years by Berkshire Hathaway stock and a lack of appealing elephant-sized takeover targets make the idea of paying a dividend- even a one-time special one- worthwhile for Berkshire Hathaway.InvestorPlace - Stock Market News, Stock Advice & Trading Tips A Growing Problem for Berkshire HathawayCalling BRK.B a cash-generating machine would be an understatement. By design, the organization is set up to produce copious amounts of cash flows from its underlying holdings. Its insurance companies pull in billions from their investments, while Buffett receives billions each quarter in dividends from BRK.B's massive stakes in companies like Coca-Cola (NYSE:KO) and U.S. Bancorp (NYSE:USB). And we can't forget about the dividends/distributions that Berkshire Hathaway's subsidiaries send back to their parent.Historically, Buffett has used this cash primarily to invest in its current businesses, buy new businesses and repurchase Berkshire Hatahaway stock when its shares are cheap enough.The problem is that BRK.B may be producing too much cash these days. At the end of 2018, BRK.B had about $112 billion in cash and equivalents on its balance sheet. That balance has only grown as more of its positions have paid their quarterly dividends into the firm's coffers.The issue is that Buffett and Berkshire are having trouble finding ways to spend that cash.With stocks surging over the last year or so, valuations aren't as cheap as Buffett would like. After all, he is a value investor. As a result, it's difficult for Berkshire to buy more shares of companies in which it already has stakes .Meanwhile, expensive valuations make buying companies outright an expensive proposition. Since Berkshire Hathaway is so big, it takes a large deal to really move the needle for Berkshire Hatahawau stock. Unfortunately, Buffett and the team at Berkshire Hathaway recently haven't found any major company that they like. It's been more than three years since BRK.B carried out a substantial buyout. So, its cash keeps piling up.That could explain Buffett's recent bout of underperformance.Over the long haul, Berkshire Hathaway stock has been a great investment. Since Buffett took over, Berkshire Hathaway has managed to produce a compound annual gain of 21% , versus a compound annual gain of just 9.7% for the S&P 500 during that time.However, the last decade hasn't been so kind for Buffett. BRK.B stock has risen by 259% over the last ten years. That's not bad at all. However, the S&P has returned a total of 314% during that time. This year alone ,the S&P 500 has risen more than twice as rapidly as Berkshire Hatahaway stock. Berkshire Hathaway Should Give It All AwayThere is a relatively easy solution to the problem for Berkshire: enact a dividend of its own. Buffett has notoriously been stubborn on this issue and has said that in 10 or 20 years, the company may decide to institute a dividend. BRK has only paid a dividend once, back in 1967. However, it might be a good idea for for Berkshire Hathaway stock to start paying one.For one thing, Buffett's argument that it's better to use the money for investments is only valid if he actually puts the cash to work. Handing some of the cash back to investors as a dividend would certainly remove some of the drag on the performance. of Berkshire Hathaway stock.And Buffett wouldn't have to get rid of all of the cash. If Berkshire Hathaway last year- after kicking out the issues with Kraft Heinz (NYSE:KHC) - put 42% of its profits into dividends, it would have spent about $20 billion on the payouts. In that scenario, Buffett would still have had plenty of cash to play with. In fact, about five years ago, Buffett had only about $42 billion in cash on Berkshire's balance sheet, and he was perfectly content and performed better.By paying a dividend, BRK.B would remove one of Buffett's main complaints about Berkshire Hathaway as well. That is, that Berkshire Hathaway stock constantly trades at a huge discount to book value. If Buffett was to pay an annual dividend or even a one-time large special payout and remove some of the excess cash, the owners of Berkshire Hathaway stock would receive an improved return on their investment. Most likely, they would enjoy higher share prices and higher net asset value. Here's Hoping Berkshire Hathaway Starts Paying UpBuffett is an amazing investor and has steered Berkshire Hathaway towards enviable returns that may have been too good. BRK just throws off too much cash these days. It's a great problem to have, but it is starting to significantly hinder the performance of BRK.B stock. Initiating a one-time, special dividend or annual payout would go a long way towards removing that excess cash from Berkshire's balance sheet, while improving the performance of BRK.B stock. At the time of writing, author Aaron Levitt did not hold a position in any of the stocks mentioned. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 High-Yield REITs to Buy (Even When the Market Tanks) * 5 Great Blue-Chip Stocks to Buy Today * 7 Tech Stocks to Buy That Are Also Perfect for Retirement Compare Brokers The post Berkshire Hathaway Stock Should Pay a Special Dividend appeared first on InvestorPlace.
Coca-Cola is partnering with Netflix to promote the third season of "Stranger Things" by re-releasing New Coke. Coca-Cola launched its new formula in 1985, the same year that season three of "Stranger Things" is set. New Coke is remembered as the beverage giant's biggest misstep and a marketing failure.
Yahoo Finance's Adam Shapiro brings you today's trending stories.